Goodman Advisory Group’s DexCom DXCM Stock Holding History

Goodman Advisory Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,544	Closed	-$474K	–	91
2026 Q1	$474K	Sell	7,544 -11,944	-61%	-$832K	0.12%	67
2025 Q4	$1.29M	Buy	+19,488	New	+$1.26M	0.32%	43

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Goodman Advisory Group's DXCM Position: Q2 2026 in Review

Goodman Advisory Group sold out of DexCom (DXCM) in Q2 2026, closing a stake of 7,544 shares — an estimated $474K sold.

Goodman Advisory Group first reported a position in DXCM in Q4 2025 and held it in 2 quarters. The position peaked at $1.29M in Q4 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Goodman Advisory Group reported no remaining DexCom position as of Q2 2026 after selling out during the quarter.
Goodman Advisory Group sold 7,544 DexCom shares in Q2 2026, an estimated $474K.
Goodman Advisory Group first reported a position in DexCom in Q4 2025 and held it in 2 quarters.
Goodman Advisory Group's DexCom position peaked at $1.29M in Q4 2025.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Goodman Advisory Group's 13F filing for Q2 2026, filed 12 Aug 2026.